Nonspecific interstitial pneumonia after peripheral blood stem cell transplantation in an 11-year-old boy

Keiji Matsumoto1, Hidetake Yabuuchi, Yoshio Matsuo

  • 1Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan.

Journal of Thoracic Imaging
|February 27, 2009
PubMed

Insights

Late-onset pulmonary complications, including infections and interstitial pneumonias, can occur after peripheral blood stem cell transplantation. This case highlights a patient who developed both pulmonary infection and nonspecific interstitial pneumonia post-transplant.

Area of Science:

  • Hematology
  • Pulmonology
  • Pediatric Oncology

Background:

  • Peripheral blood stem cell transplantation (PBSCT) is a life-saving procedure for various hematologic malignancies.
  • Late-onset pulmonary complications (LOPCs) are a significant concern following PBSCT, encompassing infections and interstitial lung diseases.
  • Diagnosing interstitial pneumonias can be challenging due to overlapping imaging findings.

Observation:

  • A case study of an 11-year-old boy treated for recurrent acute lymphocytic leukemia (ALL) with PBSCT.
  • The patient consecutively developed a pulmonary infection and then cellular nonspecific interstitial pneumonia (NSIP).
  • These pulmonary complications manifested 9 months after the PBSCT procedure.

Findings:

  • The study details a rare instance of sequential pulmonary infection and NSIP in a pediatric patient post-PBSCT.
  • It underscores the diagnostic difficulties in differentiating various interstitial lung diseases based on imaging alone.
  • The temporal relationship between the infection and NSIP provides insights into potential pathogenetic mechanisms.

Implications:

  • This case emphasizes the importance of vigilant monitoring for LOPCs in pediatric PBSCT recipients.
  • It highlights the need for advanced diagnostic approaches to distinguish between infectious and non-infectious pulmonary conditions.
  • Understanding these complications can inform future management strategies and improve outcomes for young patients undergoing stem cell transplantation.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...